These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27143961)

  • 21. Therapeutic options for palmoplantar pustulosis.
    Adişen E; Gürer MA
    Clin Exp Dermatol; 2010 Apr; 35(3):219-22. PubMed ID: 19874337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral alitretinoin treatment in patients with palmoplantar pustulosis inadequately responding to standard topical treatment: a randomized phase II study.
    Reich K; Graff O; Mehta N
    Br J Dermatol; 2016 Jun; 174(6):1277-81. PubMed ID: 26800106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment patterns and healthcare resource utilization in palmoplantar pustulosis patients in Japan: A claims database study.
    Miyazaki C; Sruamsiri R; Mahlich J; Jung W
    PLoS One; 2020; 15(5):e0232738. PubMed ID: 32442204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biologic therapies associated with development of palmoplantar pustulosis and palmoplantar pustular psoriasis: a systematic review.
    Lu JD; Lytvyn Y; Mufti A; Zaaroura H; Sachdeva M; Kwan S; Abduelmula A; Kim P; Yeung J
    Int J Dermatol; 2023 Jan; 62(1):12-21. PubMed ID: 35128653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular detection of fungal and bacterial DNA from pustules in patients with palmoplantar pustulosis: special focus on Malassezia species.
    Matsumoto Y; Harada K; Maeda T; Egusa C; Hirano H; Okubo Y; Tsuboi R
    Clin Exp Dermatol; 2020 Jan; 45(1):36-40. PubMed ID: 31220362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin (IL)-8 and IL-36γ but not IL-36Ra are related to acrosyringia in pustule formation associated with palmoplantar pustulosis.
    Xiaoling Y; Chao W; Wenming W; Feng L; Hongzhong J
    Clin Exp Dermatol; 2019 Jan; 44(1):52-57. PubMed ID: 29896852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical characteristics, quality of life and risk factors for severity in palmoplantar pustulosis: a cross-sectional, multicentre study of 263 patients.
    Sarıkaya Solak S; Kara Polat A; Kilic S; Oguz Topal I; Saricaoglu H; Karadag AS; Canpolat F; Kartal SP; Deveci BN; Kacar N; Polat Ekinci A; Guner R; Polat M; Dogan G; Guler Ozden M; Bulbul Baskan E; Ozaydin Yavuz G; Adisen E; Gulekon A; Tanribilir ME; Yilmaz O; Akman Karakas A; Ozturk P; Didar Balci D; Gonulal M; Yondem H; Turel Ermertcan A; Sendur N; Topyildiz H; Korkmaz S; Alpsoy E
    Clin Exp Dermatol; 2022 Jan; 47(1):63-71. PubMed ID: 34236713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Palmoplantar pustular psoriasis: successful therapy with efalizumab after non-response to infliximab.
    Wozel G; Vitéz L; Meurer M
    Acta Dermatovenerol Alp Pannonica Adriat; 2008 Sep; 17(3):133-6. PubMed ID: 18853077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retrospective study of the clinical significance of the neutrophil-to-lymphocyte ratio in 79 patients with palmoplantar pustulosis.
    Watanabe T; Watanabe Y; Asai C; Asami M; Takamura N; Yamaguchi Y
    J Dermatol; 2024 May; ():. PubMed ID: 38760982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased expression of IL-17A and limited involvement of IL-23 in patients with palmo-plantar (PP) pustular psoriasis or PP pustulosis; results from a randomised controlled trial.
    Bissonnette R; Nigen S; Langley RG; Lynde CW; Tan J; Fuentes-Duculan J; Krueger JG
    J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1298-305. PubMed ID: 24112799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adalimumab in the management of palmoplantar psoriasis.
    Ghate JV; Alspaugh CD
    Dermatol Online J; 2009 Jul; 15(7):15. PubMed ID: 19903443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alefacept is safe and efficacious in the treatment of palmar plantar pustulosis.
    Guenther LC
    J Cutan Med Surg; 2007; 11(6):202-5. PubMed ID: 18042332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. UVA1 phototherapy in the treatment of palmoplantar pustulosis: a pilot prospective study.
    Su LN; Xu X; Tang L; Yu N; Ding YF
    Lasers Med Sci; 2016 Nov; 31(8):1641-1643. PubMed ID: 27437986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adalimumab in the management of palmoplantar psoriasis.
    Ghate JV; Alspaugh CD
    J Drugs Dermatol; 2009 Dec; 8(12):1136-9. PubMed ID: 20027943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploratory Efficacy Evaluation of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: 32-Week Results from a Phase 2, Randomized, Placebo-Controlled Study.
    Okubo Y; Terui T; Kobayashi S; Sano S; Morita A; Imafuku S; Tada Y; Abe M; Yaguchi M; Kimura T; Shimauchi J; Zhang W; Amouzadeh H; Murakami M
    Dermatol Ther (Heidelb); 2024 Jul; 14(7):1863-1873. PubMed ID: 38896381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis, Screening and Treatment of Patients with Palmoplantar Pustulosis (PPP): A Review of Current Practices and Recommendations.
    Freitas E; Rodrigues MA; Torres T
    Clin Cosmet Investig Dermatol; 2020; 13():561-578. PubMed ID: 32884319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-17 receptor A blockade with brodalumab in palmoplantar pustular psoriasis: Report on four cases.
    Pinter A; Wilsmann-Theis D; Peitsch WK; Mössner R
    J Dermatol; 2019 May; 46(5):426-430. PubMed ID: 30786053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenic role of palatine tonsils in palmoplantar pustulosis: A review.
    Harabuchi Y; Takahara M
    J Dermatol; 2019 Nov; 46(11):931-939. PubMed ID: 31556151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of ustekinumab in refractory palmoplantar pustular psoriasis.
    Morales-Múnera C; Vilarrasa E; Puig L
    Br J Dermatol; 2013 Apr; 168(4):820-4. PubMed ID: 23210683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Epidemiology of Palmoplantar Pustulosis: An Analysis of Multiple Health Insurance Claims and Electronic Health Records Databases.
    Ramcharran D; Strober B; Gordon K; DeKlotz C; Fakharzadeh S; Yang YW; Swerdel J; Hardin J; Dronavalli S; Paller AS
    Adv Ther; 2023 Nov; 40(11):5090-5101. PubMed ID: 37737889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.